Hamman-Rich syndrome: Difference between revisions
Jump to navigation
Jump to search
(→Causes) |
(→Causes) |
||
Line 31: | Line 31: | ||
*[[Interferon gamma]] | *[[Interferon gamma]] | ||
* [[Nitrofurantoin]] | * [[Nitrofurantoin]] | ||
*[[Panitumumab]] | |||
==[[Hamman-Rich syndrome differential diagnosis|Differentiating Hamman-Rich syndrome from other Diseases]]== | ==[[Hamman-Rich syndrome differential diagnosis|Differentiating Hamman-Rich syndrome from other Diseases]]== |
Revision as of 20:13, 29 January 2015
Hamman–Rich syndrome | |
Classification and external resources | |
Micrograph of diffuse alveolar damage, the histologic correlate of acute interstitial pneumonitis. H&E stain. | |
ICD-10 | J84.1 |
ICD-9 | 516.3 |
OMIM | 178500 |
DiseasesDB | 4815 |
MeSH | D011658 |
Hamman-Rich syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hamman-Rich syndrome On the Web |
American Roentgen Ray Society Images of Hamman-Rich syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Acute interstitial pneumonia; Acute interstitial pneumonitis; HR syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamman-Rich syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies